BNP PARIBAS FINANCIAL MARKETS - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$198,786,000
+101.2%
52,312
+169.5%
0.00%
Q4 2019$98,787,000
+45.1%
19,408
+44.1%
0.00%
Q3 2019$68,076,000
+18.3%
13,467
+44.4%
0.00%
Q2 2019$57,535,000
-29.4%
9,325
-46.9%
0.00%
Q1 2019$81,460,000
+71988.5%
17,556
+64922.2%
0.00%
Q4 2018$113,000
-99.3%
27
-98.9%
0.00%
Q3 2018$15,976,000
-22.0%
2,5480.0%0.00%
Q2 2018$20,486,000
-88.2%
2,548
-89.0%
0.00%
Q1 2018$173,236,000
+0.0%
23,222
-20.2%
0.00%
Q4 2017$173,222,000
-33.4%
29,113
-17.6%
0.00%
-100.0%
Q3 2017$259,977,000
+86.2%
35,323
+71.8%
0.00%
Q2 2017$139,636,000
+14.1%
20,565
+58.7%
0.00%
Q1 2017$122,352,000
+1186.2%
12,961
+1077.2%
0.00%
Q4 2016$9,513,000
-68.1%
1,101
-76.6%
0.00%
Q3 2016$29,808,000
+176.0%
4,709
+84.0%
0.00%
Q2 2016$10,799,000
-88.5%
2,559
-83.3%
0.00%
Q4 2015$94,120,000
+14.3%
15,354
+6.6%
0.00%
Q3 2015$82,362,000
+90.6%
14,399
+148.5%
0.00%
Q2 2015$43,223,000
+337.3%
5,794
+250.5%
0.00%
Q1 2015$9,885,000
-52.7%
1,653
-58.9%
0.00%
Q3 2014$20,879,000
+3689.3%
4,023
+2478.8%
0.00%
Q1 2014$551,000
-86.6%
156
-79.8%
0.00%
Q4 2013$4,115,000
-94.8%
772
-95.1%
0.00%
Q3 2013$78,588,000
-3.4%
15,655
-14.2%
0.00%
Q2 2013$81,333,00018,2360.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
ARDSLEY ADVISORY PARTNERS LP 1,255,000$5,823,0001.12%
Phocas Financial Corp. 1,146,292$5,319,0000.54%
Worth Venture Partners, LLC 138,357$641,0000.36%
RICE HALL JAMES & ASSOCIATES, LLC 2,293,179$10,640,0000.34%
Monashee Investment Management LLC 240,000$1,114,0000.26%
BKS ADVISORS, LLC 118,587$550,0000.22%
PINNACLE ASSOCIATES LTD 1,418,391$6,581,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 4,200,820$19,492,0000.15%
Fosun International Ltd 472,580$2,174,0000.14%
CARILLON TOWER ADVISERS, INC. 3,948,024$18,318,0000.13%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders